Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Integration of Immuno-Oncology into Contemporary Management of Muscle-invasive Urothelial Carcinoma
June 2024
At the European Association of Urology (EAU) 2024 Conference, Jürgen Gschwend (Department of Urology, Hopital Rechts der Isar Technical…
Read more
30th November 2023
Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2- advanced breast cancer
The presentation focused on advancing the treatment of oestrogen-receptor positive (ER+) human epidermal growth factor receptor…
27th November 2023
Translating Science into Patient Care: How are we treating muscle invasive bladder cancer patients today?
Watch our latest webinar on muscle invasive bladder cancer (MIBC), which outlines the journey of patients with MIBC, and key treatment…
15th November 2023
Future Clinical Perspective of HRD Testing in Ovarian Cancer Samples Using NGS CGP
Explore the significance of homologous recombination deficiency (HRD) in ovarian cancer. This fantastic webinar delves into methods and…
6th November 2023
Rethinking Cancer Therapies: Fresh Perspectives on MDM2-p53, HER2, DLL3 and Other Targets in Cancer
Experience a fresh take on cancer therapies as we bring you the latest symposium from the European Society for Medical Oncology’s (ESMO)…
26th October 2023
Live Webinar: How to Translate Science into Patient Care, Long Term Outcomes in Clinical Trials | 13th November 3:00 PM - 4:00 PM GMT
This webinar will explore the impact of long term outcomes in clinical trials on clinical decision making.
26th October 2023
Live Webinar: Direct impact of in house rapid Lung NGS on cancer patients outcomes | 21th December 4:00 PM - 5:00 PM GMT
In this webinar, Francesco Passiglia, MD, Associate Professor of Medical Oncology. University of Turin will summarize the complex landscape of the NSCLC precision oncology biomarkers and treatments.
5th October 2023
Live Webinar: Future Clinical Perspective of HRD Testing in Ovarian Cancer Samples Using NGS CGP | October 26th 5:00 PM - 6:00 PM BST
This webinar will present a short overview of when it is important to consider comprehensive genomic profiling (CGP) and its role in clinical research of solid tumors.
26th September 2023
The Beginning of a New Era: Where Are We Going with Immunotherapies in Resectable NSCLC?
At the European Society for Thoracic Surgeons (ESTS) 2023 Conference Erin Gillaspie, Department of Thoracic Surgery, Vanderbilt…
Loading posts...
« Previous
1
2
3
4
…
46
Next »